Eva Lion

3.7k total citations · 1 hit paper
64 papers, 2.6k citations indexed

About

Eva Lion is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Eva Lion has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 32 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Eva Lion's work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (30 papers) and CAR-T cell therapy research (29 papers). Eva Lion is often cited by papers focused on Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (30 papers) and CAR-T cell therapy research (29 papers). Eva Lion collaborates with scholars based in Belgium, Uganda and Netherlands. Eva Lion's co-authors include Evelien Smits, Viggo Van Tendeloo, Zwi Berneman, Sébastien Anguille, Yannick Willemen, Diana Campillo-Davó, Heleen H. Van Acker, Jorrit De Waele, Herman Goossens and Elly Marcq and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Eva Lion

60 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical use of dendritic cells for cancer therapy

2014 541 citations Sébastien Anguille, Evelien Smits et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Lion Belgium	29	1.9k	1.3k	731	277	215	64	2.6k
Sébastien Anguille Belgium	29	1.7k 0.9×	1.5k 1.1×	873 1.2×	426 1.5×	219 1.0×	88	2.7k
Robbert van der Voort Netherlands	28	1.4k 0.7×	1.1k 0.8×	658 0.9×	281 1.0×	170 0.8×	43	2.4k
Willemijn Hobo Netherlands	26	1.5k 0.8×	1.3k 1.0×	520 0.7×	322 1.2×	132 0.6×	50	2.2k
Martin Felices United States	36	3.2k 1.7×	2.2k 1.6×	869 1.2×	391 1.4×	75 0.3×	97	4.1k
Liquan Gao United Kingdom	21	1.1k 0.6×	782 0.6×	574 0.8×	236 0.9×	436 2.0×	31	1.9k
Fabrice Lemaı̂tre France	32	2.5k 1.3×	1.1k 0.8×	717 1.0×	88 0.3×	234 1.1×	50	3.4k
Andrei I. Chapoval United States	25	3.4k 1.8×	2.0k 1.5×	645 0.9×	105 0.4×	99 0.5×	60	4.4k
Beatrice Schuler‐Thurner Germany	31	2.9k 1.5×	1.7k 1.3×	1.4k 1.9×	94 0.3×	158 0.7×	68	3.7k
Robin Parihar United States	22	1.5k 0.8×	1.4k 1.0×	482 0.7×	68 0.2×	197 0.9×	47	2.3k
Susana Inogés Spain	28	1.8k 1.0×	1.2k 0.9×	912 1.2×	145 0.5×	192 0.9×	65	3.0k

Countries citing papers authored by Eva Lion

Since Specialization

Citations

This map shows the geographic impact of Eva Lion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Lion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Lion more than expected).

Fields of papers citing papers by Eva Lion

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Lion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Lion. The network helps show where Eva Lion may publish in the future.

Co-authorship network of co-authors of Eva Lion

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Lion. A scholar is included among the top collaborators of Eva Lion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Lion. Eva Lion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Audenaerde, Jonas R.M. Van, Delphine Quatannens, Eva Lion, et al.. (2025). Apolipoprotein E4 facilitates transfection of human monocyte-derived dendritic cells by lipid nanoparticles. International Journal of Pharmaceutics. 678. 125720–125720.

Harizaj, Aranit, Dominika Berdecka, Eva Lion, et al.. (2024). Photoporation of NK-92MI cells with biodegradable polydopamine nanosensitizers as a promising strategy for the generation of engineered NK cell therapies. Applied Materials Today. 40. 102402–102402. 4 indexed citations

Bossche, Jolien Van den, Paul Germonpré, Y. Valcke, et al.. (2024). Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study. PLoS ONE. 19(7). e0307204–e0307204. 4 indexed citations

Reu, Hans De, Diana Campillo-Davó, Yannick Willemen, et al.. (2023). In vitro expansion of Wilms’ tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells. STAR Protocols. 4(1). 102053–102053. 2 indexed citations

Campillo-Davó, Diana, et al.. (2023). One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation. STAR Protocols. 4(1). 102112–102112. 1 indexed citations

Elias, George, Pieter Meysman, Esther Bartholomeus, et al.. (2022). Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination. eLife. 11. 11 indexed citations

Roex, Gils, Diana Campillo-Davó, Hans De Reu, et al.. (2022). Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells. Journal of Translational Medicine. 20(1). 124–124. 39 indexed citations

Waart, Anniek B. van der, Diana Campillo-Davó, Hanny Fredrix, et al.. (2020). PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity. Bone Marrow Transplantation. 55(12). 2308–2318. 15 indexed citations

Roex, Gils, Kristien Wouters, Diana Campillo-Davó, et al.. (2020). Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma. Journal of Hematology & Oncology. 13(1). 164–164. 123 indexed citations

10.

Marcq, Elly, et al.. (2018). Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer. Frontiers in Immunology. 9. 394–394. 75 indexed citations

11.

Lion, Eva, et al.. (2016). IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation. Pharmacology & Therapeutics. 170. 73–79. 25 indexed citations

12.

Anguille, Sébastien, Evelien Smits, Christian Bryant, et al.. (2015). Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews. 67(4). 731–753. 122 indexed citations

13.

Acker, Heleen H. Van, Sébastien Anguille, Viggo Van Tendeloo, & Eva Lion. (2015). Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. OncoImmunology. 4(8). e1021538–e1021538. 52 indexed citations

14.

Lion, Eva, Charlotte M. de Winde, Viggo Van Tendeloo, & Evelien Smits. (2014). Loading of Acute Myeloid Leukemia Cells with Poly(I:C) by Electroporation. Methods in molecular biology. 1139. 233–241.

15.

Anguille, Sébastien, Eva Lion, Jurjen Tel, et al.. (2012). Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential. PLoS ONE. 7(12). e51851–e51851. 47 indexed citations

16.

Anguille, Sébastien, Eva Lion, Yannick Willemen, et al.. (2011). Interferon-α in acute myeloid leukemia: an old drug revisited. Leukemia. 25(5). 739–748. 88 indexed citations

17.

Anguille, Sébastien, Eva Lion, Evelien Smits, Zwi Berneman, & Viggo Van Tendeloo. (2011). Dendritic cell vaccine therapy for acute myeloid leukemia: Questions and answers. Human Vaccines. 7(5). 579–584. 26 indexed citations

18.

Lion, Eva, et al.. (2011). Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC. PLoS ONE. 6(6). e20952–e20952. 34 indexed citations

19.

Smits, Evelien, Nathalie Cools, Eva Lion, et al.. (2009). The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells. Cancer Immunology Immunotherapy. 59(1). 35–46. 54 indexed citations

20.

Lion, Eva, Evelien Smits, Zwi Berneman, & Viggo Van Tendeloo. (2009). Quantification of IFN-γ produced by human purified NK cells following tumor cell stimulation: Comparison of three IFN-γ assays. Journal of Immunological Methods. 350(1-2). 89–96. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact